QualificationsProfessional Registration, Registered by the Ontario Board of Examiners, Psychology, 1989. Ph.D., Rutgers, The State University of New Jersey, Psychology, 1988. M.Sc., Rutgers, The State University of New Jersey, Psychology, 1984. B.A., McGill University, Psychology, 1980. Degree of Collegial Studies, Vanier College, Social Sciences, 1977. Expertise and Research InterestsThe role of psychological factors (e.g., contextual cues, affect, personality traits) in the perception and reporting of physical symptoms. Questions have been applied to several clinical domains, including menopausal hot flushes, chronic pain, as wellas symptom reporting within the context of clinical drug trials. The content and structure of illness cognitions, and how they drive health care use, adherence, and satisfaction with medical care. Current research is focused on better understanding the distinction people make between 'traditional/medical' and 'alternative' treatment approaches. Future ResearchIn the near future, there are two sets of questions I'm interested in pursing. The first set pertains to the role that psychological processes (both dispositional and method-induced) play in influencing the outcomes of clinical trials, particularly thosethat include 'soft' (i.e., self-report) outcome measures. These questions should be of particular interest to the pharmaceutical industy. The second set of questions pertains to the role of illness cognitions in the self-regulation of chronic diseases (e.g., hypertension, diabetes). Industrial RelevanceRelevance to the Pharmaceutical Industry: Drug trial participants' reports of symptomatic improvement and side effects arguably might be influenced by their general dispositions and their pre-existing beliefs. Moreover, methodological variations within studies (such as how reports of adverse-effects are elicited, or variations in informed consent procedures) inadvertently could affect the extent to which reported improvement or side effect reports are driven by subjects' expectations. These non-pharmacological factors, if left uncontrolled (methodologically and/or statistically), could spuriously inflate effect sizes under some circumstances. Under other circumstances, failing to take these non-pharmacological factors into account can increase the error variance in a trial, thereby reducing effect sizes. KeywordsCOS Keywords:Behavioral Medicine, Chronic Pain, Health Care, Health Psychology, Medical Decision Making, Menopause, Pain, Psychology, Psychophysiology, Psychosomatic Disorders, Stress, Women's Health.Additional Terms:Behavioral Medicine, Chronic Pain, Clinical Trials, Health Psychology, Illness Behavior, Illness Cognitions, Medical Decision Making, Menopause, Pain, Physical Symptom, Physical Symptom Reporting, Placebo Effects, Psychophysiology, Psychosomatic Medicine, Psychosomatics, Women's Health.Languages(Reading, Writing, Speaking)French: (Functional, Basic, Functional) Hebrew: (Basic, Basic, Functional) Yiddish: (Basic, Basic, Basic) MembershipsAmerican Psychological Association Canadian Psychological Association International Society for Traumatic Stress Studies Society of Behavioral Medicine Previous Positions1988-1993, Assistant Professor,
University of Western Ontario,
Social Science,
Psychology
1987-1988, Lecturer,
University of Western Ontario
1987-1987, Postdoctoral Fellow,
Lafayette Clinic,
Behavioral Medicine Laboratory
1985-1986, Psychology Intern,
Rush University Medical Center
Funding Received
Publications
Profile DetailsLast Updated: 1/16/2007 COS Expertise ID #919042 Reference this profile directly: http://myprofile.cos.com/swartzml11 Individual Expertise profile of Leora Celia Swartzman, Copyright Leora Celia Swartzman. © COS ExpertiseTM, 2010, ProQuest LLC All rights reserved. |